The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions

Journal of Clinical Pharmacology

Volumn 39, Issue 12, 1999, Pages 1203-1211

  Yu, D K ^a  

^a IQVIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,9 DIDEOXYFORSKOLIN; ADENYLYLIMIDODIPHOSPHATE; ANTINEOPLASTIC AGENT; CHLORPROMAZINE; CIPROFLOXACIN; CYCLOSPORIN A; CYTOCHROME P450 3A; DOCETAXEL; DOXORUBICIN; ENOXACIN; ENZYME INHIBITOR; ERYTHROMYCIN; ETOPOSIDE; FLUMEQUINE; GLYCOPROTEIN; KETOCONAZOLE; MIDAZOLAM; MIKAMYCIN B; MONOCLONAL ANTIBODY; NIFEDIPINE; NORFLOXACIN; QUINIDINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RESERPINE; RHODAMINE 123; TALINOLOL; TERFENADINE; UNINDEXED DRUG; VERAPAMIL; VINBLASTINE;

CANCER; CANCER CHEMOTHERAPY; COMPETITIVE INHIBITION; DRUG DISPOSITION; DRUG PENETRATION; DRUG PROTEIN BINDING; DRUG TRANSPORT; ENZYME INHIBITION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MULTIDRUG RESISTANCE; NORMAL HUMAN; REVIEW; TRANSCYTOSIS;

EID: 0033328139     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912709922012006     Document Type: Review

References (35)

1. Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics
2. Membrane transporters in drug disposition
3. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
4. P-glycoproteins: Mediators of multidrug resistance
5. The functional role of P-glycoprotein in the blood-brain barrier
6. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy
7. Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers
8. Interaction of pristinamycin Ia with P-glycoprotein in human intestinal epithelial cells
9. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in Caco-2 cells
10. Active secretion of the fluoroquinolone ciprofloxacin by human intestinal epithelial Caco-2 cell layer
11. Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin, and pefloxacin: A common secretory pathway?
12. Terfenadine (Seldane): A new drug for restoring sensitivity to multidrug resistant cancer cells
13. Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport
14. Interaction with P-glycoprotein and transport of erythromycin, midazolam, and ketoconazole in Caco-2 cells
15. Grapefruit juice activates P-glycoprotein-mediated drug transport
16. The digoxin-propafenone interaction: Characterization of a mechanism using renal tubular cell monolayers
17. Evidence for intestinal secretion as an additional clearance pathway of talinolol enantiomers: Concentration- and dose-dependent absorption in vitro and in vivo
18. Inhibition of intestinal P-glycoprotein and effects on etoposide absorption
19. P-glycoprotein-mediated transport of itraconazole across the blood-brain barrier
20. Effect of the P-glycoprotein inhibitor, SDZ PSC 833, on the blood and brain pharmacokinetics of colchicine
21. Inhibition of the intestinal digoxin absorption and exsorption by quinidine
22. The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers
23. Increased systemic toxicity of sarcoma chemotherapy due to combination with the P-glycoprotein inhibitor cyclosporin
24. Effect of clarithromycin on renal excretion of digoxin: Interaction with P-glycoprotein
25. Digoxin-itraconazole interaction: Possible mechanisms
26. Reversal of daunorubicin resistance in P388/ADR cells by itraconazole
27. Inhibition of the intestinal digoxin absorption and exsorption by quinidine
28. MDR-1 expression and response to vincristine, doxorubicin, and dexamethasone chemotherapy in multiple myeloma refractory to alkylating agents
29. Clinical modulation of multidrug resistance in multiple myeloma: Effect of cyclosporine on resistant tumor cells
30. Effects of corticosteroids on the expression of cytochromes P450 and on cyclosporin aoxidase activity I primary cultures of human hepatocytes
31. Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells
32. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonist and calmodulin inhibitors
33. Primary dexamethasone treatment of multiple myeloma
34. P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high dose verapamil
35. Effects of intestinal CYP3A4 and P-glycoprotein on oral drug absorption: Theoretical approach